Pharvaris (PHVS) Profit After Tax (QoQ) (2020 - 2026)
Pharvaris (PHVS) Profit After Tax (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Pharvaris | 2.23 Bn | 1.94 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.65% |
| Dec 31, 2025 | -25.32% |
| Sep 30, 2025 | 15.67% |
| Jun 30, 2025 | -5.62% |
| Mar 31, 2025 | -31.23% |
| Dec 31, 2024 | 18.91% |
| Sep 30, 2024 | -43.07% |
| Jun 30, 2024 | -5.19% |
| Mar 31, 2024 | 13.61% |
| Dec 31, 2023 | -37.16% |
| Sep 30, 2023 | -7.73% |
| Jun 30, 2023 | 1.83% |
| Mar 31, 2023 | 39.26% |
| Dec 31, 2022 | -367.28% |
| Sep 30, 2022 | 36.45% |
| Jun 30, 2022 | 25.13% |
| Mar 31, 2022 | -100.00% |
| Dec 31, 2021 | 325,342,357.35% |
| Sep 30, 2021 | 41.96% |
| Jun 30, 2021 | -152.63% |